Literature DB >> 32558474

Amplifying RNA Vaccine Development.

Deborah H Fuller1, Peter Berglund1.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32558474     DOI： 10.1056/NEJMcibr2009737

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  23 in total

Review 1.  mRNA Vaccines: Why Is the Biology of Retroposition Ignored?

Authors:  Tomislav Domazet-Lošo
Journal:  Genes (Basel)       Date:  2022-04-20       Impact factor: 4.141

Review 2.  Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine.

Authors:  Lara Milane; Mansoor Amiji
Journal:  Drug Deliv Transl Res       Date:  2021-01-29       Impact factor: 4.617

3.  Injection site vaccinology of a recombinant vaccinia-based vector reveals diverse innate immune signatures.

Authors:  Jessamine E Hazlewood; Troy Dumenil; Thuy T Le; Andrii Slonchak; Stephen H Kazakoff; Ann-Marie Patch; Lesley-Ann Gray; Paul M Howley; Liang Liu; John D Hayball; Kexin Yan; Daniel J Rawle; Natalie A Prow; Andreas Suhrbier
Journal:  PLoS Pathog       Date:  2021-01-13       Impact factor: 6.823

Review 4.  Ongoing Clinical Trials of Vaccines to Fight against COVID-19 Pandemic.

Authors:  Chiranjib Chakraborty; Ashish Ranjan Sharma; Manojit Bhattacharya; Garima Sharma; Rudra P Saha; Sang-Soo Lee
Journal:  Immune Netw       Date:  2021-01-19       Impact factor: 6.303

Review 5.  Essential considerations during vaccine design against COVID-19 and review of pioneering vaccine candidate platforms.

Authors:  Maryam Bayat; Yahya Asemani; Sajad Najafi
Journal:  Int Immunopharmacol       Date:  2021-04-15       Impact factor: 5.714

Review 6.  Perspectives on RNA Vaccine Candidates for COVID-19.

Authors:  Pobitra Borah; Pran Kishore Deb; Nizar A Al-Shar'i; Lina A Dahabiyeh; Katharigatta N Venugopala; Vinayak Singh; Pottathil Shinu; Snawar Hussain; Satyendra Deka; Balakumar Chandrasekaran; Da'san M M Jaradat
Journal:  Front Mol Biosci       Date:  2021-03-25

Review 7.  Strategies for Vaccination: Conventional Vaccine Approaches Versus New-Generation Strategies in Combination with Adjuvants.

Authors:  Abdellatif Bouazzaoui; Ahmed A H Abdellatif; Faisal A Al-Allaf; Neda M Bogari; Saied Al-Dehlawi; Sameer H Qari
Journal:  Pharmaceutics       Date:  2021-01-22       Impact factor: 6.321

Review 8.  From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape.

Authors:  Chiranjib Chakraborty; Ashish Ranjan Sharma; Manojit Bhattacharya; Sang-Soo Lee
Journal:  Front Immunol       Date:  2021-07-07       Impact factor: 7.561

9.  Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio.

Authors:  Erika J Crosby; Amy C Hobeika; Donna Niedzwiecki; Christel Rushing; David Hsu; Peter Berglund; Jonathan Smith; Takuya Osada; William R Gwin Iii; Zachary C Hartman; Michael A Morse; Herbert Kim Lyerly
Journal:  J Immunother Cancer       Date:  2020-11       Impact factor: 13.751

Review 10.  Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines.

Authors:  Katie L Flanagan; Emma Best; Nigel W Crawford; Michelle Giles; Archana Koirala; Kristine Macartney; Fiona Russell; Benjamin W Teh; Sophie Ch Wen
Journal:  Front Immunol       Date:  2020-10-02       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.